Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T4090 (Kinezodianone R HCl) in open-angle glaucoma or ocular hypertension
NCT06394973Phase 2Completed
- Sponsor
- Laboratoires Théa
- Start
- Aug 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Kinezodianone R hydrochloride in open-angle glaucoma (OAG), ocular hypertension, sponsored by Laboratoires Théa. Started Aug 2024; status: completed.
02
Drugs
Kinezodianone R hydrochloride
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT06394973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06394973.